Safety of Monoclonal Antibodies in Children Affected by SARS-CoV-2 Infection

被引:13
|
作者
Romani, Lorenza [1 ]
Carducci, Francesca Ippolita Calo [1 ]
Chiurchiu, Sara [1 ]
Cursi, Laura [1 ]
De Luca, Maia [1 ]
Di Giuseppe, Martina [1 ]
Krzysztofiak, Andrzej [1 ]
Lancella, Laura [1 ]
Palma, Paolo [2 ,3 ]
Vallesi, Leonardo [4 ]
Corsetti, Tiziana [4 ]
Campana, Andrea [5 ]
Nicastri, Emanuele [6 ]
Rossi, Paolo [3 ,7 ]
Bernardi, Stefania [1 ]
机构
[1] Bambino Gesu Pediat Hosp, Immunol & Infect Dis Unit, IRCCS, I-00165 Rome, Italy
[2] Bambino Gesu Pediat Hosp, Res Unit Congenital & Perinatal Infect, IRCCS, I-00165 Rome, Italy
[3] Univ Roma Tor Vergata, Dept Syst Med, Chair Pediat, I-00133 Rome, Italy
[4] Bambino Gesu Pediat Hosp, Hosp Pharm Unit, IRCCS, I-00165 Rome, Italy
[5] Bambino Gesu Pediat Hosp, Dept Pediat, IRCCS, I-00165 Rome, Italy
[6] IRCCS, Natl Inst Infect Dis, I-00149 Rome, Italy
[7] Bambino Gesu Pediat Hosp, Acad Dept Pediat, IRCCS, I-00165 Rome, Italy
来源
CHILDREN-BASEL | 2022年 / 9卷 / 03期
关键词
COVID-19; monoclonal antibody; children;
D O I
10.3390/children9030369
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Monoclonal antibody therapies for COVID-19 have been frequently used in adults, whereas there are little data regarding the safety or efficacy of monoclonal antibody treatments in pediatric patients affected by COVID-19. We report our experience in the administration of mAb as a treatment for SARS-CoV-2 infection in children aged from 24 days to 18 years old.
引用
收藏
页数:6
相关论文
共 50 条
  • [31] Reduced sensitivity of the SARS-CoV-2 Lambda variant to monoclonal antibodies and neutralizing antibodies induced by infection and vaccination
    Wang, Meiyu
    Zhang, Li
    Li, Qianqian
    Wang, Bo
    Liang, Ziteng
    Sun, Yeqing
    Nie, Jianhui
    Wu, Jiajing
    Su, Xiaodong
    Qu, Xiaowang
    Li, Yuhua
    Wang, Youchun
    Huang, Weijin
    EMERGING MICROBES & INFECTIONS, 2022, 11 (01) : 18 - 29
  • [32] Monoclonal antibody therapies in the management of SARS-CoV-2 infection
    Miguez-Rey, Enrique
    Choi, Dasom
    Kim, Seungmin
    Yoon, Sangwook
    Sandulescu, Oana
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2022, 31 (01) : 41 - 58
  • [33] A human monoclonal antibody blocking SARS-CoV-2 infection
    Wang, Chunyan
    Li, Wentao
    Drabek, Dubravka
    Okba, Nisreen M. A.
    van Haperen, Rien
    Osterhaus, Albert D. M. E.
    van Kuppeveld, Frank J. M.
    Haagmans, Bart L.
    Grosveld, Frank
    Bosch, Berend-Jan
    NATURE COMMUNICATIONS, 2020, 11 (01)
  • [34] SARS-CoV-2 infection is not associated with the emergence of monoclonal gammopathies
    Simonini, Cecilia
    Natali, Patrizia
    Pirotti, Tommaso
    Nasillo, Vincenzo
    Riva, Giovanni
    Chester, Johanna
    Trenti, Tommaso
    Debbia, Daria
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2024, 46 (03) : 451 - 456
  • [35] Monoclonal SARS-CoV-2 Antibodies in Pregnancy-a Case Series
    Zoellkau, Janine
    Reuken, Philipp A.
    Schleussner, Ekkehard
    Groten, Tanja
    DEUTSCHES ARZTEBLATT INTERNATIONAL, 2022, 119 (07): : 113 - 114
  • [36] SARS-CoV-2 mutations: A strain on efficacy of neutralizing monoclonal antibodies?
    Boskovic, Marko
    Migo, William
    Likic, Robert
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 87 (11) : 4476 - 4478
  • [37] Monoclonal neutralizing antibodies against SARS-COV-2 S protein
    Cheng, Lin-Dong
    Li, Ping
    Lin, Yan-Chen
    Hu, Hui-Xiu
    Zhang, Ying
    Li, Hou-Feng
    Huang, Jing
    Tan, Li
    Ma, Ning
    Xia, Deng-Yun
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2024, 16 (02): : 681 - 689
  • [38] Development of SARS-CoV-2 specific neutralizing recombinant monoclonal antibodies
    Desai, Pavitra
    Karuppuchamy, Thangaraj
    Syed, Nazia
    Unnikrishnan, Sarath
    Mathivanan, Raghul
    Priya, Nancy
    Balasubramanian, Rajesh
    Bhattiprolu, Krishna
    Sundarraj, Swathi
    Sridharan, Haripriya
    JOURNAL OF IMMUNOLOGY, 2022, 208 (01):
  • [39] Monoclonal antibodies neutralizing circulating SARS-CoV-2 variants of concern
    Kovacech, Branislav
    Fialova, Lubica
    Filipcik, Peter
    Skrabana, Rostislav
    Zilkova, Monika
    Kovac, Andrej
    Rolkova, Gabriela Paulikova
    Tomkova, Katarina
    Csokova, Natalia Turic
    Markova, Karina
    Skrabanova, Michaela
    Majerova, Petra
    Hanes, Jozef
    Cehlar, Ondrej
    Cente, Martin
    Piestansky, Juraj
    Slavikova, Monika
    Borsova, Kristina
    Cabanova, Viktoria
    Brejova, Bronislava
    Vinar, Tomas
    Nosek, Jozef
    Klempa, Boris
    Eyer, Ludek
    Honig, Vaclav
    Palus, Martin
    Ruzek, Daniel
    Vyhlidalova, Tereza
    Strakova, Petra
    Mrazkova, Blanka
    Zudova, Dagmar
    Koubkova, Gizela
    Novosadova, Vendula
    Prochazka, Jan
    Sedlacek, Radislav
    Zilka, Norbert
    Kontsekova, Eva
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2023, 53 : 53 - 54
  • [40] Protective non-neutralizing SARS-CoV-2 monoclonal antibodies
    Izadi, Arman
    Nordenfelt, Pontus
    TRENDS IN IMMUNOLOGY, 2024, 45 (08) : 609 - 624